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Vitamin D is a multifunctional micronutrient that exerts 
hormonal effects on many organs of the body. 1,25   
dihydroxyvitamin D is the active metabolite of vitamin 
D, formed by dual hydroxylation in the liver and kidney 
(Figure 1).1 Circulating 1,25 dihydroxyvitamin D exerts 
biological functions, mainly through interaction with 
vitamin D receptors (VDRs), and can increase the     
intestinal absorption of mineral ions such as calcium 
and phosphate; it can also suppress the biosynthesis of 
parathyroid hormone. High serum levels of 1,25        
dihydroxyvitamin D are believed to increase              
osteoclastic bone resorption, which mobilizes calcium 
and phosphate from bone. Of relevance, vitamin D is a 
strong inducer of fibroblast growth factor 23 (FGF23) 
and klotho, two important homeostatic regulators of 
calcium and phosphate metabolism.2-4   
 
An association between hypovitaminosis D and age-
associated disorders, including osteoporosis, cancer, 
diabetes, autoimmune disorders, hypertension, athero-
sclerosis, and muscle weakness is reported; a similar 
association is also noted with neurological disorders 
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including multiple sclerosis, Alzheimer’s disease,   
Parkinson’s disease, and schizophrenia.5 However, it is 
not yet clear whether such associations are a cause or 
consequence of vitamin D deficiency. In addition,      
calcium supplements along with vitamin D are         
commonly used to delay the progression of               
osteoporosis, but the expected benefit of calcium and 
vitamin D supplements are minimized by the potential 
risk of cardiovascular events, including vascular        
calcification.6,8 In fact, studies have documented that 
calcium supplements increased the risk of myocardial 
infarction and stroke, as high as 30%.9,10 Consumption 
of vitamin D and calcium supplements can also enhance 
the risk of developing cardiovascular calcification in the 
elderly.11-13 We believe that harmful consequences of 
cardiovascular effects following calcium and vitamin D 
ingestion may be partly related to dysregulated phos-
phate balance.1,14-16   
 
A wide range of vitamin-D fortified food is currently 
consumed with the anticipation that such fortified food 
and drink can maintain bone health by preventing    
skeletal disorders, including rickets. Food fortification is 
an accepted practice in many countries, although many 
types of food fortification were historically outlawed in 
several European countries.17 This policy was strength-
ened in Europe after England’s epidemic of adverse 
effects in children who were fed vitamin-D fortified 
foods during the 1950s. As well as promoting sales of 
fortified “junk” food, investigators cited potential       
fortification-related risks from ingesting excessive 
micronutrients that do not exist in natural whole foods, 
which may lead to metabolic imbalances.    
 
Nutrition authorities also point out that supplements 
cannot replace food as a primary source of nutrients in a 
balanced diet. Nevertheless, the 1994 Dietary            
Supplement Health and Education Act passed by the 
U.S. Congress allows supplements to be released on the 
market without evidence of safety or effectiveness, 
thereby fueling an explosive growth in marketing      
suspect dietary supplements.18 As a result, rather than 
use as a backup nutritional plan, there may be an       
increasing reliance on supplementation and fortification 
to balance an unhealthy diet, which undermines the     
public's motivation to obtain essential nutrients from 
consuming natural whole foods. The false sense of     
security and convenience provided by swallowing a pill 
Fig 1: Different stages of vitamin D synthesis1 
Simplified diagram of the different stages of vitamin D    
synthesis. Please note that the molecular regulation of      
vitamin D synthesis is much complex, and for the simplicity, 
we have only mentioned some of the essential events of   
vitamin synthesis.1 VDR: vitamin D receptor. 
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or eating fortified ‘junk food’ implies that                  
supplementation and fortification may reinforce        
dependency on supplements as a quick fix rather than 
encourage healthier eating practices. For example, most 
people who rely on supplements instead of food said 
they “find it hard to eat a balanced diet".19  
 
Furthermore, serum 25-hydroxyvitamin D levels in 
many countries are generally lower than in Western 
populations where vitamin D supplementation and food 
fortification is more common. Thus, by Western       
standards, vitamin D deficiency in global populations is 
apparent, but is it a real phenomenon? Studies of 25 
hydroxyvitamin within global populations need to     
document whether applying the higher Western standard 
of serum concentrations is a valid indicator of true     
vitamin D deficiency. For example, global populations 
with darker skin color, greater skin coverage from       
clothing, and less exposure to natural sunlight have little 
trouble maintaining health with lower serum                  
25-hydroxyvitamin D levels. Promoting higher             
25-hydroxyvitamin D levels may benefit the supplement 
industry and the practitioners who prescribe                
supplements, but it is not supported by evidence of 
health outcomes in global populations. In fact, bone 
health in global populations with lower vitamin D 
status, such as in Asian countries, is often far better than 
in vitamin-D supplemented populations in North     
America and Europe.20   
 
It has been known for almost a century that moderate 
sun exposure is sufficient to ensure adequate vitamin D 
levels and eliminate rickets.21 It is believed that that 
“Ten to 15 minutes of sunshine three times weekly is 
enough to produce the body's requirement of vitamin D. 
The sun needs to shine on the skin of your face, arms, 
back, or legs (without sunscreen)” This amount of        
vitamin D is all that is required to promote healthy bone 
growth and prevent rickets; unfortunately, rickets is 
once again reappearing as safe sun exposure falls out of 
favor with the general public over concerns of skin     
cancer.22 Ironically, evidence shows that outdoor     
workers have lower skin cancer risk than indoor       
workers. 
 
In summary, vitamin D produced naturally from         
adequate exposure to sunlight is necessary to prevent 
health problems like rickets, which is unquestioned. 
That vitamin D supplementation is necessary for health 
remains questionable, and uncontrolled use of vitamin D 
supplements, in addition to consumption of vitamin D 
fortified food, may induce unexpected adverse effects. 
The overall benefits of calcium and vitamin D           
supplementation to osteoporotic patients is not yet      
settled. Of relevance, citing the U.S. Preventive        
Services Task Force investigation of vitamin D and    
calcium supplementation, Nestle et al.23 pointed out that 
there is no solid evidence of benefits from vitamin D 
supplementation that are worth even the smallest risk. 
Additionally, experimental studies suggest that cardio-
vascular calcification due to excessive levels of calcium 
and vitamin D may be partly related to dysregulated 
phosphate balance.14,24-29 
Several final points remain to be raised regarding      
vitamin supplements. The argument that these           
substances are safe for use until toxic effects appear is 
as incongruous as arguing that tobacco use is safe until 
cancer appears. Safety is not exclusively a quantitative 
issue concerning the accumulation of toxic effects, but 
also includes the qualitative issue concerning the nature 
of the substance's interactions with the body. Many    
supplements derived from animal and plant extracts as 
well as laboratory synthesized analogues do not        
function as natural or native nutrients. They are        
qualitatively foreign substances to the human body, they 
often produce a pharmacological effect by interfering 
with normal physiological mechanisms, and they also 
have adverse effects as do most of the drugs. It is not up 
to independent researchers to verify that these            
substances are unsafe and ineffective for use; the onus 
should rightfully be on the manufacturers and promotors 
of these substances to prove that their supplements and 
patented pharmaceutical products are safe and effective, 
especially for long-term use, but the evidence shows 
they have neglected to do so by effectively using the 
loopholes of regulations. 
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